stella
beta
Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression — Stella
Recruiting
Back to Ovarian Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
Israel
The Chaim Sheba Medical Center, Ramat Gan
Tel Aviv Sourasky Medical Center (Ichilov Hospital), Tel Aviv
View full record on ClinicalTrials.gov